• Autolus Therapeutics announce new time for investor call to discuss data presented at the 63rd ASH Annual Meeting & Exposition

    Source: Nasdaq GlobeNewswire / 06 Dec 2021 07:00:00   America/New_York

    LONDON, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced it will hold a conference call to discuss the data being presented at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition, being held between December 11-14, 2021. Note this is a change to the timing announced previously.

    New timing of investor call

    Management will host a conference call and webcast on Monday, December 13, 2021, at 8:00 am ET/1:00 pm GMT to discuss the ASH data. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus’ website.

    Conference Dial in:

    • United States and Canada (866) 679-5407
    • International (409) 217-8320
    • Conference ID 31044873

    Replay:
    A replay will be available for one week following the call

    • United States and Canada (855) 859-2056
    • International (404) 537-3406
    • Conference ID 31044873

    About Autolus Therapeutics plc
    Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. For more information, please visit www.autolus.com.

    Contact:

    Lucinda Crabtree, PhD
    Vice President, Business Strategy and Planning
    +44 (0) 7587 372 619 
    l.crabtree@autolus.com

    Julia Wilson
    +44 (0) 7818 430877
    j.wilson@autolus.com

    Susan A. Noonan
    S.A. Noonan Communications
    +1-212-966-3650
    susan@sanoonan.com


    Primary Logo

Share on,